DGAP-News: Evonik Industries AG / Key word(s): Expansion Evonik Industries AG: Evonik begins basic engineering for an additional methionine plant in Singapore (news with additional features) 03.03.2016 / 09:00 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Embargoed until: March 3, 2016, 7 a.m. Evonik begins basic engineering for an additional methionine plant in Singapore - Global increase in demand for DL-methionine in animal nutrition - Second fully backward-integrated plant planned in Singapore - Targeted annual capacity of 150,000 metric tons Evonik Industries has started basic engineering for the construction of a second world-scale production plant for the amino acid DL-methionine in Singapore. The plant complex, with a projected annual production capacity of 150,000 metric tons, is expected to come on stream in 2019. The Evonik committees have now approved the basic engineering. The decision is based on the continuing increase in the demand for sustainable animal nutrition. "We have supported the strong market growth of DL-methionine over the years by timely and needs-driven expansion of our production capacities, and we plan to continue doing this," says Klaus Engel, Chairman of the Executive Board of Evonik. The specialty chemicals group markets DL-methionine under the MetAMINO(R) brand name. The new complex will be erected next to Evonik's existing methionine plant on Jurong Island, Singapore, which was commissioned in late 2014. "Like our first methionine plant in Singapore, which went on stream on schedule, this project too is progressing according to plan," explains Reiner Beste, chairman of the Board of the Management of Evonik Nutrition & Care GmbH. Singapore was once again selected as the site because Evonik can service the Asian growth market particularly well from there. And once again, in the new, fully backward-integrated production complex, Evonik will produce all strategically important precursors itself. "This guarantees high product quality as well as supply security," says Beste. The specialty chemicals group is already producing DL-methionine at world-scale plants in Antwerp (Belgium), Wesseling/Cologne (Germany), Mobile (Alabama, USA), and Singapore. DL-methionine is an essential amino acid that must be supplied in feed. As a feed additive it contributes toward efficient, healthy, and ecofriendly nutrition of agricultural livestock, particularly poultry and pigs. Population growth and rising standards of living are leading in many regions of the world to an increase in meat consumption, which in turn increases demand for methionine. The addition of this and other amino acids to animal feeds allows the raw protein content to be significantly reduced. This reduces the burden on the environment by reducing resource consumption, the greenhouse effect, and the potential for eutrophication and acidification. Evonik translates over 60 years of experience in manufacturing essential amino acids for animal nutrition into solutions that meet the evolving needs of its customers in over one hundred countries. As Evonik now expands its scope to innovative nutritional feed additive solutions beyond amino acids, customers can count on Evonik to take nutrient effectiveness ever further and keep delivering value along with consistent quality. Around the planet, Evonik products and services are and will continue to be key to producing healthy, affordable food with fewer natural resources and a smaller environmental footprint. Company information Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals, operating in the Nutrition & Care, Resource Efficiency and Performance Materials segments. The company benefits from its innovative prowess and integrated technology platforms. In 2015 more than 33,500 employees generated sales of around EUR13.5 billion and an operating profit (adjusted EBITDA) of about EUR2.47 billion. About Nutrition & Care The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,000 employees, and generated sales of around EUR4.9 billion in 2015. Disclaimer In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release. Contact: Contact Person Economic Press Alexandra Boy Deputy Head of Corporate Press Phone +49 201 177-3167 Fax +49 201 177-3030 [email protected] Contact Person Specialized Press Dr. Jürgen Krauter Vice President Communications/ Nutrition & Care Phone +49 6181 59-6847 Fax +49 6181 59-76847 [email protected] Evonik Industries AG Rellinghauser Straße 1-11 45128 Essen Phone +49 201 177-01 Fax +49 201 177-3475 www.evonik.de Supervisory Board Dr. Werner Müller, Chairman Executive Board Dr. Klaus Engel, Chairman Dr. Ralph Sven Kaufmann Christian Kullmann Thomas Wessel Ute Wolf Registered Office: Essen Register Court: Essen Local Court Commercial Registry B 19474 VAT no. DE 811160003 +++++ Additional features: Document: http://n.eqs.com/c/fncls.ssp?u=YPFSGXJMAK Document title: PM ME6 --------------------------------------------------------------------------- 03.03.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Evonik Industries AG Rellinghauser Straße 1-11 45128 Essen Germany Phone: +49 (0) 201 177-01 Fax: +49 (0) 201 177-3475 E-mail: [email protected] Internet: www.evonik.com ISIN: DE000EVNK013, XS0911405784 WKN: EVNK01, A1TM7T Indices: MDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Hanover, Munich, Stuttgart; Terminbörse EUREX; Luxemburg End of News DGAP News Service --------------------------------------------------------------------------- 442033 03.03.2016